Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis-Reference-Cited by-同舟云学术

Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis

Published:2023-07-19 Issue:7 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Zacharias Harry D¹,Kamel Fady¹,Tan Jaclyn²,Kimer Nina³,Gluud Lise Lotte⁴,Morgan Marsha Y¹

Affiliation:

1. UCL Institute for Liver & Digestive Health; Division of Medicine, Royal Free Campus, University College London; London UK

2. UCL Institute for Liver & Digestive Health, Division of Medicine, Royal Free Campus, University College London; London UK

3. Gastrounit; Medical Division, Copenhagen University Hospital Hvidovre; Hvidovre Denmark

4. Gastrounit, Medical Division; Copenhagen University Hospital Hvidovre; Hvidovre Denmark

Publisher

Wiley

Subject

Pharmacology (medical)

Reference424 articles.

1. Lactulose alone versus lactulose + rifaximin for the management of hepatic encephalopathy;Ahmed;Pakistan Journal of Medical and Health Sciences,2018

2. Efficacy of rifaximin in prevention of recurrence of hepatic encephalopathy in patients with cirrhosis of liver;Ali;Journal of the College of Physicians and Surgeons Pakistan,2014

3. Rifaximin versus placebo preventing the recurrence of clinically overt hepatic encephalopathy in patients having cirrhosis of liver;Babar;Medical Forum,2017

4. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy;Bajaj;Gastroenterology,2011

5. Rifaximin in minimal hepatic encephalopathy clinicaltrials.gov/ct2/show/NCT00533910

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic encephalopathy: investigational drugs in preclinical and early phase development;Expert Opinion on Investigational Drugs;2023-11-02

2. How does rifaximin with or without non-absorbable disaccharides compare with non-absorbable disaccharides alone for people with cirrhosis?;Cochrane Clinical Answers;2023-10-13